Received Jun 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
she's (physician) not seeing the antibodies she is looking for; This spontaneous report was received from a pharmacist on 04-Jun-2025 and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date (a long time ago), the patient may be vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), (lot # and expiration date were not reported) as prophylaxis (it was stated that the reporter was uncertain as the patient may have never received it). In April 2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot # and expiration date were not reported) as prophylaxis. The physician wanted the patient to receive Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) because the physician not seeing the antibodies she was looking for (Antibody test negative). The reporter inquired about dosing interval between the two vaccines. At the reporting time, the outcome of the event was unknown. The action taken with the vaccines was not applicable. The causal relationship between the event and both of the vaccines not provided. Batch/lot number is being requested and will be submitted if received.